Israeli startup CytoReason today announced a partnership with Swiss multinational, Ferring Pharmaceuticals, to establish new treatments for inflammatory bowel disease (IBD).
Read more here.
Israeli startup CytoReason today announced a partnership with Swiss multinational, Ferring Pharmaceuticals, to establish new treatments for inflammatory bowel disease (IBD).
Read more here.
![[Trusona in Security Boulevard] NEW TECH: ‘Passwordless authentication’ takes us closer to eliminating passwords as the weak link](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
